Geometry Dash APK Hill Climb Racing APK
45.8 F
New York
Thursday, February 25, 2021

Enzolytics Inc (OTCMKTS:ENZC) Continues to Move Higher On Massive Volume

Must read

Greene Concepts (OTCMKTS:INKW) Hits New High: Soars 500% in a 2-Week Span

It is a well-known fact that one of the best ways of going about investing in stocks is...

Healthier Choices Management Corp (HCMC) Stock Rockets on WallStreetBets Chatter

Over the past couple of weeks, members from Reddit investment community WallStreetBets have unleashed mayhem in the markets by pumping heavily shorted...

Bombardier, Inc. (OTCMKTS:BDRBF) Uptrend at Risk: In Focus

British company Bombardier, Inc. (OTCMKTS:BDRBF) came into sharp focus among investors last week after a significant development. Major Triggers

Sunhydrogen Inc (OTCMKTS:HYSR) Continues to Trend Higher on High Demand

One of the sectors to have come into significant focus among investors in recent times is the hydrogen...

Companies that are working on ways to tackle HIV are almost always an attractive proposition for investors, especially if the companies in question show some progress.

One such company could be Enzolytics Inc (OTCMKTS:ENZC) and in recent days, its stock has also performed impressively.

Key Triggers

Following an announcement from the company on Monday, the Enzolytics stock rallied strongly and went up by as much as 28% yesterday. The latest rally in Enzolytics Inc (OTCMKTS:ENZC) took its gains over the course of the past month to as much as 300%.

The rally experienced by the stock this week was linked to an announcement made by the company with regards to the latest discovery.

Enzolytics announced on February 1 that it managed to identify as many as seven new conserved and possibly immutable sites on the HIV virus. However, that is not all. The company also announced that it is now aiming to come up with anti-HIV monoclonal antibodies that are meant for specifically targeting those sites.

It is a major development for the company and it was no surprise that the news was welcomed with such optimism by investors. At this point in time, the anti-HIV monoclonal antibody from Enzolytics can target only one such site.

The discovery of new sites is a welcome development since the company is now going to start working on producing anti-HIV monoclonal antibodies Institute for Preclinical Studies at Texas A&M University. However, that is not all.

Last month, Enzolytics announced that it got the official filing receipt from the United States Patent Office with regards to its multiple sclerosis patent application.

The application in question is titled “Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor – Pharmaceutical Composition for Treatment”. More importantly, it is necessary to point out that Enzolytics also received the third tranche of financing worth as much as $1.2 million.

Disclaimer: We hold no position in ENZC stock

Latest article

Blockchain Technologies Ltd (OTCMKTS:HVBTF) Makes A Stunning Move on Blockchain Optimism

The cryptocurrency boom has sustained for many months now and it anything; it is expected to continue in the future.

Enzolytics Inc (OTCMKTS:ENZC) In Focus: Regains It’s Momentum

One of the most notable gainers over the course of the past months has been the Enzolytics Inc stock. While it is...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Medmen Enterprises Inc (OTCMKTS:MMNFF) Pulls Back From Highs as Buzz Cools Off

Among the sectors which have bounced back in 2021, the cannabis sector is one of considerable interest since it had been in...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...